Brief: SynAct Pharma Q1 Pretax Loss Widens To SEK 4.7 Mln
24/04/2019 12:06
April 24 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q1 PRETAX LOSS SEK 4.7 MILLION VERSUS LOSS SEK 3.5 MILLION
YEAR
AGO
Source text for Eikon: ID:nNDL27Bqr1
Further company coverage: SYNACT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026